Molecular Optical Imaging of Therapeutic Targets of Cancer

Konstantin Sokolov, Dawn Nida, Michael Descour, Alicia Lacy, Matthew Levy, Brad Hall, Su Dharmawardhane, Andrew Ellington, Brian Korgel, Rebecca Richards-Kortum

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Recent progress in discerning the molecular events that accompany carcinogenesis has led to development of new cancer therapies directly targeted against the molecular changes of neoplasia. Molecular-targeted therapeutics have shown significant improvements in response rates and decreased toxicity as compared to conventional cytotoxic therapies which lack specificity for tumor cells. In order to fully explore the potential of molecular-targeted therapy, a new set of tools is required to dynamically and quantitatively image and monitor the heterogeneous molecular profiles of tumors in vivo. Currently, molecular markers can only be visualized in vitro using complex immunohistochemical staining protocols. In this chapter, we discuss emerging optical tools to image in vivo a molecular profile of risk-based hallmarks of cancer for selecting and monitoring therapy. We present the combination of optically active, targeted nanoparticles for molecular imaging with advances in minimally invasive optical imaging systems, which can be used to dynamically image both a molecular and phenotypic profile of risk and to monitor changes in this profile during therapy.

Original languageEnglish (US)
Pages (from-to)299-344
Number of pages46
JournalAdvances in Cancer Research
Volume96
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Molecular Imaging
Optical Imaging
Neoplasms
Molecular Targeted Therapy
Therapeutics
Optical Devices
Nanoparticles
Carcinogenesis
Staining and Labeling

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Sokolov, K., Nida, D., Descour, M., Lacy, A., Levy, M., Hall, B., ... Richards-Kortum, R. (2006). Molecular Optical Imaging of Therapeutic Targets of Cancer. Advances in Cancer Research, 96, 299-344. https://doi.org/10.1016/S0065-230X(06)96011-4

Molecular Optical Imaging of Therapeutic Targets of Cancer. / Sokolov, Konstantin; Nida, Dawn; Descour, Michael; Lacy, Alicia; Levy, Matthew; Hall, Brad; Dharmawardhane, Su; Ellington, Andrew; Korgel, Brian; Richards-Kortum, Rebecca.

In: Advances in Cancer Research, Vol. 96, 2006, p. 299-344.

Research output: Contribution to journalArticle

Sokolov, K, Nida, D, Descour, M, Lacy, A, Levy, M, Hall, B, Dharmawardhane, S, Ellington, A, Korgel, B & Richards-Kortum, R 2006, 'Molecular Optical Imaging of Therapeutic Targets of Cancer', Advances in Cancer Research, vol. 96, pp. 299-344. https://doi.org/10.1016/S0065-230X(06)96011-4
Sokolov, Konstantin ; Nida, Dawn ; Descour, Michael ; Lacy, Alicia ; Levy, Matthew ; Hall, Brad ; Dharmawardhane, Su ; Ellington, Andrew ; Korgel, Brian ; Richards-Kortum, Rebecca. / Molecular Optical Imaging of Therapeutic Targets of Cancer. In: Advances in Cancer Research. 2006 ; Vol. 96. pp. 299-344.
@article{42b503e1cfd04d549621e56d33d9297c,
title = "Molecular Optical Imaging of Therapeutic Targets of Cancer",
abstract = "Recent progress in discerning the molecular events that accompany carcinogenesis has led to development of new cancer therapies directly targeted against the molecular changes of neoplasia. Molecular-targeted therapeutics have shown significant improvements in response rates and decreased toxicity as compared to conventional cytotoxic therapies which lack specificity for tumor cells. In order to fully explore the potential of molecular-targeted therapy, a new set of tools is required to dynamically and quantitatively image and monitor the heterogeneous molecular profiles of tumors in vivo. Currently, molecular markers can only be visualized in vitro using complex immunohistochemical staining protocols. In this chapter, we discuss emerging optical tools to image in vivo a molecular profile of risk-based hallmarks of cancer for selecting and monitoring therapy. We present the combination of optically active, targeted nanoparticles for molecular imaging with advances in minimally invasive optical imaging systems, which can be used to dynamically image both a molecular and phenotypic profile of risk and to monitor changes in this profile during therapy.",
author = "Konstantin Sokolov and Dawn Nida and Michael Descour and Alicia Lacy and Matthew Levy and Brad Hall and Su Dharmawardhane and Andrew Ellington and Brian Korgel and Rebecca Richards-Kortum",
year = "2006",
doi = "10.1016/S0065-230X(06)96011-4",
language = "English (US)",
volume = "96",
pages = "299--344",
journal = "Advances in Cancer Research",
issn = "0065-230X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Molecular Optical Imaging of Therapeutic Targets of Cancer

AU - Sokolov, Konstantin

AU - Nida, Dawn

AU - Descour, Michael

AU - Lacy, Alicia

AU - Levy, Matthew

AU - Hall, Brad

AU - Dharmawardhane, Su

AU - Ellington, Andrew

AU - Korgel, Brian

AU - Richards-Kortum, Rebecca

PY - 2006

Y1 - 2006

N2 - Recent progress in discerning the molecular events that accompany carcinogenesis has led to development of new cancer therapies directly targeted against the molecular changes of neoplasia. Molecular-targeted therapeutics have shown significant improvements in response rates and decreased toxicity as compared to conventional cytotoxic therapies which lack specificity for tumor cells. In order to fully explore the potential of molecular-targeted therapy, a new set of tools is required to dynamically and quantitatively image and monitor the heterogeneous molecular profiles of tumors in vivo. Currently, molecular markers can only be visualized in vitro using complex immunohistochemical staining protocols. In this chapter, we discuss emerging optical tools to image in vivo a molecular profile of risk-based hallmarks of cancer for selecting and monitoring therapy. We present the combination of optically active, targeted nanoparticles for molecular imaging with advances in minimally invasive optical imaging systems, which can be used to dynamically image both a molecular and phenotypic profile of risk and to monitor changes in this profile during therapy.

AB - Recent progress in discerning the molecular events that accompany carcinogenesis has led to development of new cancer therapies directly targeted against the molecular changes of neoplasia. Molecular-targeted therapeutics have shown significant improvements in response rates and decreased toxicity as compared to conventional cytotoxic therapies which lack specificity for tumor cells. In order to fully explore the potential of molecular-targeted therapy, a new set of tools is required to dynamically and quantitatively image and monitor the heterogeneous molecular profiles of tumors in vivo. Currently, molecular markers can only be visualized in vitro using complex immunohistochemical staining protocols. In this chapter, we discuss emerging optical tools to image in vivo a molecular profile of risk-based hallmarks of cancer for selecting and monitoring therapy. We present the combination of optically active, targeted nanoparticles for molecular imaging with advances in minimally invasive optical imaging systems, which can be used to dynamically image both a molecular and phenotypic profile of risk and to monitor changes in this profile during therapy.

UR - http://www.scopus.com/inward/record.url?scp=33845215120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845215120&partnerID=8YFLogxK

U2 - 10.1016/S0065-230X(06)96011-4

DO - 10.1016/S0065-230X(06)96011-4

M3 - Article

C2 - 17161684

AN - SCOPUS:33845215120

VL - 96

SP - 299

EP - 344

JO - Advances in Cancer Research

JF - Advances in Cancer Research

SN - 0065-230X

ER -